Business Standard

Piramal Enterprises Q3 consolidated net rises 21% to Rs 4.9 billion

Pharma segment revenues grew by 7% to Rs 10.22 bn

Ajay Piramal
Premium

Ajay Piramal

Abhijit Lele Mumbai
Piramal Enterprises, which straddles finance, pharma and healthcare segments, posted a 21% rise in net profit at Rs 4.9 billion in third quarter ended December 2017 (Q3FY18) mainly on account of improved operational performance.

However, growth in profits was partly offset by increase in tax expenses.

It had posted a net profit of Rs 4.04 billion in October-December 2016 (Q3FY17).

Ajay Piramal, chairman, PEL said the consistency in performance is outcome of robust business model, sharp focus on quality, compliance, legal and risk mitigation across businesses.

The income from financial services rose by 46% at Rs 13.16 billion for Q3FY18 from Rs 9.02  billion

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 30 2018 | 5:12 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com